Annual report pursuant to Section 13 and 15(d)

REVENUES FROM CONTRACTS WITH CUSTOMERS - Disaggregation of net revenues (Details)

v3.24.1
REVENUES FROM CONTRACTS WITH CUSTOMERS - Disaggregation of net revenues (Details) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
REVENUES FROM CONTRACTS AND SIGNIFICANT CUSTOMERS    
Product revenues $ 59,662 $ 70,995
Qbrexza    
REVENUES FROM CONTRACTS AND SIGNIFICANT CUSTOMERS    
Product revenues 25,410 26,715
Accutane    
REVENUES FROM CONTRACTS AND SIGNIFICANT CUSTOMERS    
Product revenues 20,168 18,373
Amzeeq    
REVENUES FROM CONTRACTS AND SIGNIFICANT CUSTOMERS    
Product revenues 6,201 7,242
Targadox    
REVENUES FROM CONTRACTS AND SIGNIFICANT CUSTOMERS    
Product revenues 3,204 7,972
Exelderm    
REVENUES FROM CONTRACTS AND SIGNIFICANT CUSTOMERS    
Product revenues 2,395 3,463
Zilxi    
REVENUES FROM CONTRACTS AND SIGNIFICANT CUSTOMERS    
Product revenues 1,962 2,273
Ximino    
REVENUES FROM CONTRACTS AND SIGNIFICANT CUSTOMERS    
Product revenues 287 $ 4,957
Luxamend    
REVENUES FROM CONTRACTS AND SIGNIFICANT CUSTOMERS    
Product revenues $ 35